Eli Lilly Q3 Preview: Analysts see another quarter of earnings surprise driven led by Mounjaro, Zepbound

Eli Lilly (LLY) is expected to see a multi-fold increase in its earnings during its third quarter earnings, which is ...
Fierce Pharma

Lilly earmarks $1.2B for upgrades to Puerto Rico plant to boost oral drug production capacity

Picking a date for a press conference in Puerto Rico in the middle of hurricane season can be risky business. | Eli Lilly has ...
Zacks Investment Research on MSN

Buy, Sell or Hold Lilly Stock? Key Tips Ahead of Q3 Earnings

Eli Lilly and Company LLY will report its third-quarter 2025 earnings on Oct. 30, before market open. The Zacks Consensus ...
KSHB Kansas City

Eli Lilly warns 2 of its insulin products may be out of stock

Patients may have trouble finding two different types of insulin products made by Eli Lilly. The company said it's experiencing a shortage of its 10 mL vials of Humalog and Insulin Lispro Injection ...

Eli Lilly vs. Viking Therapeutics Stock: Which Is the Best Growth Opportunity, According to Wall Street?

Eli Lilly is a leader in weight loss drugs, a market that may reach $95 billion by the end of the decade. Viking Therapeutics ...

Eli Lilly Sues 2 Texas Companies Over Weight Loss Drug Replicas

Two Texas compounding pharmacies are the latest to get sued in Eli Lilly’s multi-state battle to stop sales of replica ...